By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Only nine of the 34 stocks that comprise the GenomeWeb Daily News Index gained ground during another tough month for the stock market.

Three of the companies included in the Index — Clinical Data, Compugen, and Nanosphere — were hit hardest, with all of them falling more than 20 percent for June. Clinical Data had the largest decline, closing the month down 24 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.